Specific growth rate dependent transcriptome profiling of Escherichia coli K12 MG1655 in accelerostat cultures
Specific growth rate dependent gene expression changes of Escherichia coli K12 MG1655 were studied by microarray and real-time PCR analyses. The bacteria were cultivated on glucose limited minimal medium using the accelerostat method (A-stat) where starting from steady state conditions (chemostat cu...
Gespeichert in:
Veröffentlicht in: | Journal of biotechnology 2010, Vol.145 (1), p.60-65 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Specific growth rate dependent gene expression changes of
Escherichia coli K12 MG1655 were studied by microarray and real-time PCR analyses. The bacteria were cultivated on glucose limited minimal medium using the accelerostat method (A-stat) where starting from steady state conditions (chemostat culture) dilution rate is constantly increased. At specific growth rate (
μ) 0.47
h
−1,
E. coli had focused its metabolism to glucose utilization by down-regulation of alternative substrate transporters expression compared to
μ
=
0.3
h
−1. It was found that acetic acid accumulation began at
μ
=
0.34
±
0.01
h
−1 and two acetate synthesis pathways – phosphotransacetylase-acetate kinase (
pta-ackA) and pyruvate oxidase (
poxB) – contributed to the synthesis at the beginning of overflow metabolism,
i.
e. onset of acetate excretion. On the other hand,
poxB,
pta and
ackA expression patterns suggest that pyruvate oxidase may be the only enzyme synthesizing acetate at
μ
=
0.47
h
−1. Loss of glucose and acetate co-utilization represented by down-regulation of
acs-yjcH-actP operon between specific growth rates 0.3–0.42
h
−1 and acetic acid accumulation from
μ
=
0.34
±
0.01
h
−1 allows one to surmise that the acetate utilization operon expression might play an important role in overflow metabolism. |
---|---|
ISSN: | 0168-1656 1873-4863 |
DOI: | 10.1016/j.jbiotec.2009.10.007 |